{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:17:25Z","timestamp":1790018245456,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"POLYMOD"},{"name":"UK Department of Health Policy Research Programme","award":["039\/0031"],"award-info":[{"award-number":["039\/0031"]}]},{"DOI":"10.13039\/501100000805","name":"ECDC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.11.026","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T19:32:55Z","timestamp":1322076775000},"page":"1225-1234","source":"Crossref","is-referenced-by-count":70,"title":["The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom"],"prefix":"10.1016","volume":"30","author":[{"given":"Albert Jan","family":"van Hoek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Melegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Bilcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (RR-11)","key":"10.1016\/j.vaccine.2011.11.026_bib0005","first-page":"1","article-title":"Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR [Internet]"},{"issue":"May (RR-6)","key":"10.1016\/j.vaccine.2011.11.026_bib0010","first-page":"1","article-title":"Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR [Internet]"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2011.11.026_bib0015","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.026_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.aje.a117238","article-title":"Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States","volume":"140","author":"Halloran","year":"1994","journal-title":"American Journal of Epidemiology"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.11.026_bib0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiology and Infection [Internet]"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2011.11.026_bib0030","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine [Internet]"},{"issue":"August (9334)","key":"10.1016\/j.vaccine.2011.11.026_bib0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case\u2013control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet [Internet]"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.11.026_bib0040","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bulletin of Mathematical Biology [Internet]"},{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2011.11.026_bib0045","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella\u2013zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"Journal of Medical Virology [Internet]"},{"issue":"June (25)","key":"10.1016\/j.vaccine.2011.11.026_bib0050","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0264-410X(00)00100-6","article-title":"Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes","volume":"18","author":"Brisson","year":"2000","journal-title":"Vaccine [Internet]"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.11.026_bib0055","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics [Internet]"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.026_bib0060","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"The Journal of Infectious Diseases [Internet]"},{"issue":"October","key":"10.1016\/j.vaccine.2011.11.026_bib0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.026_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics [Internet]"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2011.11.026_bib0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Review of Vaccines [Internet]"},{"issue":"March (Suppl.)","key":"10.1016\/j.vaccine.2011.11.026_bib0080","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"The Journal of Infectious Diseases [Internet]"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.11.026_bib0085","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics [Internet]"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.11.026_bib0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997\u20132002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiology and Infection [Internet]"},{"issue":"January","key":"10.1016\/j.vaccine.2011.11.026_bib0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003","volume":"5","author":"Yih","year":"2005","journal-title":"BMC Public Health [Internet]"},{"issue":"12","key":"10.1016\/j.vaccine.2011.11.026_bib0100","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.11.026_bib0105","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clinic Proceedings, Mayo Clinic [Internet]"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.026_bib0110","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Medicine [Internet]"},{"issue":"RR-5","key":"10.1016\/j.vaccine.2011.11.026_bib0115","first-page":"30","article-title":"Morbidity and mortality weekly report prevention of herpes zoster recommendations of the advisory prevention of herpes zoster: recommendation of the advisory committee on immunization practices","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR"},{"issue":"22","key":"10.1016\/j.vaccine.2011.11.026_bib0120","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"New England Journal of Medicine [Internet]"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.11.026_bib0125","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"van Hoek","year":"2009","journal-title":"Vaccine [Internet]"},{"issue":"13","key":"10.1016\/j.vaccine.2011.11.026_bib0130","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0135","series-title":"Guide to the methods of technology appraisal [Internet]","year":"2008"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0140","series-title":"Unit costs of health & social care [Internet]","year":"2007"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0145","unstructured":"Royal College of General Practitioners. Weekly returns service annual report [Internet]. Available from: http:\/\/www.rcgp.org.uk\/clinical_and_research\/rsc\/annual_reports.aspx."},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.026_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268800001278","article-title":"An analysis of infection control of varicella\u2013zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987\u201392","volume":"117","author":"Wreghitt","year":"1996","journal-title":"Epidemiology and Infection [Internet]"},{"issue":"March (Suppl.)","key":"10.1016\/j.vaccine.2011.11.026_bib0155","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"The Journal of Infectious Diseases [Internet]"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.026_bib0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"The Pediatric Infectious Disease Journal [Internet]"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.026_bib0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiology and Infection [Internet]"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0170","series-title":"Vaccines","article-title":"Varicella vaccine","author":"Gershon","year":"2008"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.11.026_bib0175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","article-title":"The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination","volume":"28","author":"Civen","year":"2009","journal-title":"The Pediatric Infectious Disease Journal [Internet]"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0180","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.11.026_bib0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clinical Infectious Diseases [Internet]"},{"issue":"November (49)","key":"10.1016\/j.vaccine.2011.11.026_bib0190","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0195","unstructured":"Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine [Internet]; (October):13\u20135 [cited 2011 October 25] available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21964056, (2011) epub ahead of print."},{"key":"10.1016\/j.vaccine.2011.11.026_bib0200","series-title":"Statistical bulletin\u20142010-based national population projections. October [Internet]","author":"Office for National Statistics","year":"2011"},{"key":"10.1016\/j.vaccine.2011.11.026_bib0210","series-title":"NHS reference costs 2006\u20132007 [Internet]","author":"Department of Health","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T08:21:01Z","timestamp":1543393261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11017932"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}